Metabolic syndrome ameliorating agent
A method for ameliorating metabolic syndrome may include administering, to a patient in need thereof, an effective amount of a monounsaturated fatty acid having 22 carbons or a salt or an ester thereof and/or an effective amount of a monounsaturated fatty acid having 20 carbons or a salt or an ester thereof.
1. A method of raising blood adiponectin concentrations, and lessening TNF-α concentration comprising administering, to a patient in need thereof,
an oil comprising an effective amount of at least one selected from (a) a monounsaturated fatty acid having 22 carbons, or a salt or an ester thereof, and (b) a monounsaturated fatty acid having 20 carbons, or a salt or an ester thereof,
wherein total amount of (a) the monounsaturated fatty acid having 22 carbons, or a salt or ester thereof, and (b) the monounsaturated fatty acid having 20 carbons, or a salt or an ester thereof is at least 50% by weight of total amount of all fatty acids present in the oil.
2. The method according to claim 1 , wherein the method comprises administering a glyceride of at least one selected from (a) the monounsaturated fatty acid having 22 carbons and (b) the monounsaturated fatty acid having 20 carbons.
3. The method according to claim 2 , wherein the glyceride is contained in a fish oil.
4. The method according to claim 1 , wherein the oil is contained in a food product.
5. The method according to claim 1 , wherein the method comprises administering an effective amount of a monounsaturated fatty acid having 22 carbons or a salt or an ester thereof, wherein the monounsaturated fatty acid having 22 carbons is docosenoic acid.
6. The method according to claim 1 , wherein the monounsaturated fatty acid having 20 carbons is icosenoic acid.
7. The method according to claim 1 , wherein the oil comprises an ester of (a) the monounsaturated fatty acid having 22 carbons and/or (b) the monounsaturated fatty acid having 20 carbons, and the oil is derived from a fish of the family Scomberesocidae, Gadidae, Salmonidae, Osmeridae, or Clupeidae.
8. The method according to claim 7 , wherein the oil is saury fish oil, or Alaska pollock oil.
9. The method according to claim 7 , the oil is MUFA-concentrated.
10. The method according to claim 1 , wherein the method comprises administering an oil comprising an effective amount of (a) the monounsaturated fatty acid having 22 carbons, or a salt or an ester thereof, and (b) the monounsaturated fatty acid having 20 carbons, or a salt or an ester thereof.